Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Electrical Stimulation in ICU Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with any clinical condition hospitalized in the ICU, which are monitored by the Physiotherapy Service:~* Cerebrovascular diseases~* Other bacterial diseases~* Circulatory and respiratory diseases~* Digestive and abdominal diseases~* Liver diseases~* Time between the patient's ICU entry and the onset of the NMES intervention less than one week.~Patients may be in mechanical ventilation, non-invasive ventilation, oxygen therapy or oxygen ambient ventilation (no ventilatory add). Patients re-admitted to the ICU within the same hospitalization period (i.e., did not leave the hospital) may also be included, as well as patients with previous tracheostomy.~Exclusion Criteria:~* Previously diagnosed neuromuscular diseases:~* ALS~* Guillain Barre~* Chronic stroke~* TRM~* End-stage malignant disease~* Lower limbs' amputation~* Body mass index above 40 kg/m2~* Cachexia (defined as the presence of chronic disease and weight loss ≥ 5% in a period shorter than 12 months or BMI \< 20 kg/m2, associated with at least three of the following criteria: (1) decreased muscle strength; (2) fatigue; (3) anorexia; (4) reduction of fat free mass index; and (5) biochemical abnormalities such as inflammation, anemia or reduction of serum albumin concentration).~* Lesions on the skin at the electrode placement and/or dynamometer support points~* Post-operative transplantation~* Patients using a neuromuscular blocker~* Hemodynamic instability (nora \> 10; ABCDE criteria)~* Height \< 1.50m~* Rhabdomyolysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neuromuscular Electrical Stimulation - NMES (Type: EXPERIMENTAL): NMES will be applied bilaterally on the quadriceps femoris muscle of ICU patients. An electrical stimulation system and an ICU-designed dynamometer will be used with the patients lying in bed, with the hips and the knees flexed at 60 and 90 degrees, respectively. Supramaximal single-pulse's peak force will be used to determine the NMES intervention level. NMES (alternating biphasic current, stimulation frequency = 80 Hz, 1 ms pulse duration) will be used to evoke tetanic forces (EF) at 50% of the supra-maximal single-pulse EF (i.e., 10-12% of a maximal voluntary isometric contraction). NMES protocol will be performed five times a week, lasting 20 min. Muscle fatigue will be evaluated every 5 min of the intervention, and will be determined as a 10 % decrease in the single-pulse evoked torque between the evoked force produced pre- and during the NMES protocol. If and when a 10% reduction of the single-pulse EF is achieved, the intervention protocol will be terminated before the 20 min.
- Control Group - CG (Type: NO_INTERVENTION): The control group (CG) will only perform conventional physiotherapy and will not receive any NMES training, but will be evaluated through the same evaluations and in the same moments of the two above mentioned intervention groups. Conventional physiotherapy will be given to all three groups.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues